8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sickness behavior and cognitive dysfunction occur frequently by unknown mechanisms in virus-infected individuals with malignancies treated with type I interferons (IFNs) and in patients with autoimmune disorders. We found that during sickness behavior, single-stranded RNA viruses, double-stranded RNA ligands, and IFNs shared pathways involving engagement of melanoma differentiation-associated protein 5 (MDA5), retinoic acid-inducible gene 1 (RIG-I), and mitochondrial antiviral signaling protein (MAVS), and subsequently induced IFN responses specifically in brain endothelia and epithelia of mice. Behavioral alterations were specifically dependent on brain endothelial and epithelial IFN receptor chain 1 (IFNAR). Using gene profiling, we identified that the endothelia-derived chemokine ligand CXCL10 mediated behavioral changes through impairment of synaptic plasticity. These results identified brain endothelial and epithelial cells as natural gatekeepers for virus-induced sickness behavior, demonstrated tissue specific IFNAR engagement, and established the CXCL10-CXCR3 axis as target for the treatment of behavioral changes during virus infection and type I IFN therapy.

          Related collections

          Author and article information

          Journal
          Immunity
          Immunity
          1097-4180
          1074-7613
          Apr 19 2016
          : 44
          : 4
          Affiliations
          [1 ] Institute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany.
          [2 ] Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Medical School Hannover, 30625 Hannover, Germany.
          [3 ] Oscar Langendorff Institute of Physiology, University of Rostock, 18057 Rostock, Germany.
          [4 ] Institute of Physiology and Pathophysiology, University of Heidelberg, 69120 Heidelberg, Germany.
          [5 ] Department of Molecular Neurobiology, Groningen Institute of Evolutionary Life Sciences, University of Groningen, and Department of Psychiatry, University Medical Center Groningen, 9700 Groningen, The Netherlands.
          [6 ] Ruhr University Bochum, Medical Faculty, Department Neurophysiology, 44780 Bochum, Germany.
          [7 ] Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Medical School Hannover, 30625 Hannover, Germany; Institute for Laboratory Animal Science, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
          [8 ] Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
          [9 ] Department of Biological Informatics and Experimental Therapeutics, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
          [10 ] Department of Neurology, Universitätsklinikum Bonn, 53105 Bonn, Germany.
          [11 ] Portland, Oregon, 97201, USA.
          [12 ] Biogen Inc., Cambridge, MA 02142, USA.
          [13 ] Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23538 Lübeck, Germany.
          [14 ] Institute of Virology, Technische Universität München/ Helmholtz-Zentrum München, 81756 München, Germany; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
          [15 ] Institute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany. Electronic address: marco.prinz@uniklinik-freiburg.de.
          Article
          S1074-7613(16)30110-8
          10.1016/j.immuni.2016.04.005
          27096319
          66fc9c97-aceb-41ea-9c22-c3ba10757035
          Copyright © 2016 Elsevier Inc. All rights reserved.
          History

          CXCL10,CXCR3,IFN,IFNAR1,IPS-1,MAVS,behavior,brain,depression,endothelia,epithelia,influenza,neurons,signal transduction,type I interferon,virus infection

          Comments

          Comment on this article